Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "LA"

9897 News Found

KIMS enters into MoU for strategic clinical collaboration
Healthcare | April 30, 2026

KIMS enters into MoU for strategic clinical collaboration

The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes


Pfizer drug delivers breakthrough in late-stage blood cancer trial
Clinical Trials | April 30, 2026

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis


Monitra Health raises fresh funding  to scale upBeat® cardiac monitoring platform globally
Medical Device | April 30, 2026

Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services


GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push
News | April 30, 2026

GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push

The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need


Solara announces closure of US FDA inspection at Puducherry facility
Drug Approval | April 30, 2026

Solara announces closure of US FDA inspection at Puducherry facility

The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action
Supply Chain | April 30, 2026

Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action

Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies


Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Biopharma | April 29, 2026

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights